HALKUFF DAWN 4
4 · XERIS PHARMACEUTICALS INC · Filed Mar 1, 2019
Insider Transaction Report
Form 4
HALKUFF DAWN
Director
Transactions
- Award
Stock Option (right to buy)
2019-02-27+20,000→ 20,000 totalExercise: $10.00Exp: 2029-02-27→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]25% of these shares shall vest on the first anniversary of the vesting commencement date, with the remainder vesting ratably over the following 36 months.